BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1552557)

  • 1. Epidemiology of breast cancer in families in Iceland.
    Tulinius H; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L
    J Med Genet; 1992 Mar; 29(3):158-64. PubMed ID: 1552557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
    J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.
    Baffoe-Bonnie AB; Kiemeney LA; Beaty TH; Bailey-Wilson JE; Schnell AH; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
    Genet Epidemiol; 2002 Nov; 23(4):349-63. PubMed ID: 12432503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial risk of prostate cancer in Iceland.
    Eldon BJ; Jonsson E; Tomasson J; Tryggvadottir L; Tulinius H
    BJU Int; 2003 Dec; 92(9):915-9. PubMed ID: 14632846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer.
    Tulinius H; Egilsson V; Olafsdóttir GH; Sigvaldason H
    BMJ; 1992 Oct; 305(6858):855-7. PubMed ID: 1422397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods.
    Sellers TA; Anderson VE; Potter JD; Bartow SA; Chen PL; Everson L; King RA; Kuni CC; Kushi LH; McGovern PG
    Genet Epidemiol; 1995; 12(4):417-29. PubMed ID: 8536958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a single BRCA2 mutation on cancer in Iceland.
    Tulinius H; Olafsdottir GH; Sigvaldason H; Arason A; Barkardottir RB; Egilsson V; Ogmundsdottir HM; Tryggvadottir L; Gudlaugsdottir S; Eyfjord JE
    J Med Genet; 2002 Jul; 39(7):457-62. PubMed ID: 12114473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic epidemiology of breast cancer: segregation analysis of 389 Icelandic pedigrees.
    Baffoe-Bonnie AB; Beaty TH; Bailey-Wilson JE; Kiemeney LA; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
    Genet Epidemiol; 2000 Jan; 18(1):81-94. PubMed ID: 10603460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk estimation in families with history of breast cancer.
    Muhonen T; Eerola H; Vehmanen P; Nevanlinna H; Aktan K; Blomqvist C; Kääriäinen H; Pyrhönen S
    Br J Cancer; 1997; 76(9):1228-31. PubMed ID: 9365174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995.
    Tulinius H; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Bjarnadóttir K
    J Med Genet; 1999 Feb; 36(2):103-7. PubMed ID: 10051006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families.
    Sellers TA; King RA; Cerhan JR; Chen PL; Grabrick DM; Kushi LH; Oetting WS; Vierkant RA; Vachon CM; Couch FJ; Therneau TM; Olson JE; Pankratz VS; Hartmann LC; Anderson VE
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1051-7. PubMed ID: 10613336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic epidemiologic aspects of gastric cancer in Iceland.
    Imsland AK; Eldon BJ; Arinbjarnarson S; Egilsson V; Tulinius H; Tryggvadóttir L; Arngrímsson R; Magnússon J
    J Am Coll Surg; 2002 Aug; 195(2):181-6; discussion 186-7. PubMed ID: 12168964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of an interaction of alcohol intake and family history on breast cancer risk in the Minnesota Breast Cancer Family Study.
    Vachon CM; Cerhan JR; Vierkant RA; Sellers TA
    Cancer; 2001 Jul; 92(2):240-8. PubMed ID: 11466675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry.
    Anton-Culver H; Kurosaki T; Taylor TH; Gildea M; Brunner D; Bringman D
    Genet Epidemiol; 1996; 13(2):193-205. PubMed ID: 8722746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoplastic diseases in families of breast cancer patients.
    Tulinius H; Olafsdottir GH; Sigvaldason H; Tryggvadottir L; Bjarnadottir K
    J Med Genet; 1994 Aug; 31(8):618-21. PubMed ID: 7815419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database.
    Slattery ML; Kerber RA
    JAMA; 1993 Oct; 270(13):1563-8. PubMed ID: 8371466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the effect of nongenetic risk factors on the familial risk of breast cancer among relatives of postmenopausal breast cancer patients.
    Chen PL; Sellers TA; Rich SS; Potter JD; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1994; 3(7):549-55. PubMed ID: 7827584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial breast cancer in Iceland.
    Tulinius H; Day NE; Bjarnason O; Geirsson G; Johannesson G; Liceaga de Gonzalez MA; Sigvaldason H; Bjarnadottir G; Grimsdottir K
    Int J Cancer; 1982 Apr; 29(4):365-71. PubMed ID: 7085127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases.
    Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H
    Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.